Stock Scorecard



Stock Summary for Caredx Inc (CDNA) - $10.52 as of 3/28/2024 11:05:27 AM EST

Total Score

9 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for CDNA

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for CDNA

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for CDNA

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for CDNA

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for CDNA

Mainz Biomed Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnostic 3/5/2024 1:01:00 PM
Unlocking Q4 Potential of CareDx ( CDNA ) : Exploring Wall Street Estimates for Key Metrics 2/26/2024 2:15:00 PM
This Top 6% Med Stock Just Blew Past A Buy Zone On Its Patent Win 1/17/2024 3:10:00 PM
CareDx Clears Technical Benchmark, Hitting 90-Plus RS Rating 12/22/2023 8:00:00 AM
How Much Upside is Left in CareDx ( CDNA ) ? Wall Street Analysts Think 26.72% 12/8/2023 2:55:00 PM
Can CareDx ( CDNA ) Climb 29.79% to Reach the Level Wall Street Analysts Expect? 11/22/2023 2:55:00 PM
CareDx ( CDNA ) Surges 16.6%: Is This an Indication of Further Gains? 11/6/2023 12:38:00 PM
NATERA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Natera, Inc. - NTRA 10/21/2023 2:50:00 AM
PM360 Announces 2023 Trailblazer Award Winners 10/4/2023 12:00:00 PM
PM360 Announces 2023 Trailblazer Award Finalists 8/24/2023 1:00:00 PM

Financial Details for CDNA

Company Overview

Ticker CDNA
Company Name Caredx Inc
Country USA
Description CareDx, Inc. discovers, develops and markets diagnostic solutions for transplant patients and caregivers globally. The company is headquartered in South San Francisco, California.
Sector Name LIFE SCIENCES
Industry Name SERVICES-MEDICAL LABORATORIES
Most Recent Quarter 12/31/2023
Next Earnings Date 5/8/2024

Stock Price History

Last Day Price 10.52
Last Day Price Updated 3/28/2024 11:05:27 AM EST
Last Day Volume 743,136
Average Daily Volume 923,778
52-Week High 12.93
52-Week Low 4.80
Last Price to 52 Week Low 119.17%

Valuation Measures

Trailing PE N/A
Industry PE 261.00
Sector PE 60.76
5-Year Average PE -3.53
Free Cash Flow Ratio 2.31
Industry Free Cash Flow Ratio 16.58
Sector Free Cash Flow Ratio 31.04
Current Ratio Most Recent Quarter 4.02
Total Cash Per Share 4.55
Book Value Per Share Most Recent Quarter 5.07
Price to Book Ratio 1.90
Industry Price to Book Ratio 2.70
Sector Price to Book Ratio 21.66
Price to Sales Ratio Twelve Trailing Months 1.92
Industry Price to Sales Ratio Twelve Trailing Months 1.49
Sector Price to Sales Ratio Twelve Trailing Months 8.77

Share Statistics

Total Shares Outstanding 51,778,000
Market Capitalization 544,704,560
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -148.37%
Reported EPS 12 Trailing Months -3.54
Reported EPS Past Year -0.64
Reported EPS Prior Year -0.39
Net Income Twelve Trailing Months -190,284,000
Net Income Past Year -190,284,000
Net Income Prior Year -76,613,000
Quarterly Revenue Growth YOY -20.40%
5-Year Revenue Growth 29.63%

Balance Sheet

Total Cash Most Recent Quarter 235,400,000
Total Cash Past Year 235,400,000
Total Cash Prior Year 293,100,000
Net Cash Position Most Recent Quarter 235,400,000
Net Cash Position Past Year 235,400,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 261,328,000
Total Stockholder Equity Prior Year 430,911,000
Total Stockholder Equity Most Recent Quarter 261,328,000

Options

Put/Call Ratio 0.22
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.03
MACD Signal 0.23
20-Day Bollinger Lower Band 7.60
20-Day Bollinger Middle Band 10.03
20-Day Bollinger Upper Band 12.46
Beta 1.42
RSI 43.52
50-Day SMA 8.87
200-Day SMA 35.27

System

Modified 3/27/2024 8:39:51 PM EST